Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Teladoc Health, Inc. (TDOC)

Teladoc Health: Chief Legal Officer Adam Vandervoort to resign effective November 1, 2026

Neutral Impact 3 of 5 leadership Written later

Teladoc Health said its Chief Legal Officer and Secretary, Adam C. Vandervoort, will resign effective November 1, 2026, with the resignation made for good reason under his executive severance agreement. Jonathan Dorfman, the company's Senior Vice President, Securities & Corporate Law, will succeed him in both roles, which matters to shareholders as a senior legal leadership change with a defined handover period.

Key points

  • Adam C. Vandervoort notified the company of his resignation on September 24, 2026, effective November 1, 2026.
  • Vandervoort will provide advisory services, including transition support, until November 1, 2027, with no compensation for those services.
  • Jonathan Dorfman will become Chief Legal Officer and Secretary after Vandervoort's departure.

The filing

CompanyTeladoc Health, Inc. (TDOC)
Form8-K, current report
Filed with the SECSep 25, 2026, 8:30 AM ET
Accession number0001477449-26-000046

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 25, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.